| Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus (NCT05424627) | Central Hospital, Nancy, France | 2022-07-15 |
| Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care Unit (NCT05418855) | Assiut University | 2022-07-01 |
| A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1) (NCT05306574) | Vor Biopharma | 2022-06-20 |
| Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology (NCT05116163) | Brigham and Women's Hospital | 2022-06-17 |
| Probiotics in Systemic Lupus Erythematosus (NCT05433857) | Ain Shams University | 2022-06-10 |
| Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study (NCT05430854) | Amgen | 2022-06-01 |
| Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus Erythmatosus (NCT05392790) | Cairo University | 2022-05-23 |
| Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus (NCT05247203) | RemeGen Co., Ltd. | 2022-05-11 |
| Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine (NCT00775476) | State University of New York - Upstate Medical University | 2022-05-05 |
| ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation) (NCT05347992) | DxTerity Diagnostics | 2022-05-03 |
| Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors (NCT04751396) | M.D. Anderson Cancer Center | 2022-04-20 |
| Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus (NCT05262686) | Peking University People's Hospital | 2022-04-01 |
| Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients (NCT05478018) | Rigshospitalet, Denmark | 2022-04-01 |
| The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) (NCT05162586) | EMD Serono Research & Development Institute, Inc. | 2022-03-31 |
| Effects of Telehealth Initiative on Lupus Patients (NCT05329831) | Selcuk University | 2022-03-15 |
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases (NCT05236491) | Paul R Fortin | 2022-03-09 |
| A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus (NCT05123586) | Eli Lilly and Company | 2022-03-07 |
| Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus (NCT05179018) | Assiut University | 2022-03-01 |
| Laser Puncture and Program of Lifestyle Modification in Lupus Females (NCT05381545) | Cairo University | 2022-02-28 |
| Prediction of Lupus Renal Flares Study (NCT05362812) | Charite University, Berlin, Germany | 2022-02-28 |
| Evaluation Of Serum MIF Level in SLE Patients (NCT05253638) | Assiut University | 2022-02-22 |
| Stress, Inflammation and Immune Response Pilot Study- Aim 3 (NCT04857151) | University of Wisconsin, Madison | 2022-02-02 |
| PRV-3279-2a Trial in Systemic Lupus (NCT05087628) | Provention Bio, a Sanofi Company | 2022-01-20 |
| Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE) (NCT05426902) | Duke University | 2022-01-03 |
| Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients (NCT05105217) | Assiut University | 2021-12-01 |
| Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus (NCT05039840) | Sanofi | 2021-11-10 |
| A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers (NCT05328557) | Cugene Inc. | 2021-11-09 |
| Sequential Belimumab and T-cell Based Therapy in SLE (NCT04447053) | National University Hospital, Singapore | 2021-11-08 |
| Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 (NCT05115370) | University of Nottingham | 2021-11-01 |
| The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy. (NCT05132621) | Medical University of Warsaw | 2021-11-01 |
| Treatment of Periodontal Disease in Systemic Lupus Erythematosus (NCT04046172) | University College, London | 2021-11-01 |
| A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus (NCT04963296) | Hoffmann-La Roche | 2021-10-26 |
| Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) (NCT04908865) | GlaxoSmithKline | 2021-10-21 |
| Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy (NCT05358652) | Fundacin Biomedica Galicia Sur | 2021-10-15 |
| A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) (NCT04895696) | Beeline Medicines Corporation | 2021-10-11 |
| Centrally Acting ACE Inhibition in SLE (NCT04486118) | Northwell Health | 2021-10-01 |
| Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus (NCT05057481) | Assiut University | 2021-09-15 |
| Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis (NCT04971590) | GlaxoSmithKline | 2021-09-14 |
| A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus (NCT05030779) | Zhejiang University | 2021-09-10 |
| Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation (NCT04902807) | Institut National de la Santé Et de la Recherche Médicale, France | 2021-09-07 |
| The Effect of Deep Breathing and Transcutaneus Electrical Nerve Stimulation on Heart Rate Variability (NCT05157334) | Aalborg University Hospital | 2021-09-01 |
| Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG) (NCT05090189) | Bruno Gualano | 2021-08-27 |
| ILD-SARDs Registry and Biorepository (NCT05007340) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-08-24 |
| A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus (NCT04882878) | Janssen Research & Development, LLC | 2021-08-20 |
| Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE) (NCT05001698) | AstraZeneca | 2021-07-27 |
| A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus (NCT04976322) | UCB Biopharma SRL | 2021-07-27 |
| Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions (NCT04833465) | Children's National Research Institute | 2021-07-16 |
| RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome (NCT03684564) | University College, London | 2021-07-09 |
| Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study (NCT04942314) | Jia Deng | 2021-07-01 |
| An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus (NCT04810754) | Charite University, Berlin, Germany | 2021-06-30 |
| ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus (NCT04835441) | Alpine Immune Sciences Inc, A Subsidiary of Vertex | 2021-06-22 |
| Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus (NCT04877691) | AstraZeneca | 2021-06-08 |
| Expression of CXCR4 in Patients With Systemic Lupus Erythematosus (NCT04799730) | Sohag University | 2021-05-01 |
| Recombinant Zoster Vaccine in Stable SLE Patients (NCT04516408) | RenJi Hospital | 2021-04-20 |
| At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring (NCT05451277) | Evelyne Vinet | 2021-04-01 |
| Efficacy and Safety of Belimumab in SLE Patients (NCT04515719) | RenJi Hospital | 2021-03-10 |
| Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases (NCT04276701) | University Hospital, Bordeaux | 2021-03-10 |
| Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus (NCT04582136) | Chinese SLE Treatment And Research Group | 2021-03-04 |
| Study of Leukocyte Populations in Patients With Chronic Inflammatory (NCT04749875) | Assistance Publique - Hôpitaux de Paris | 2021-03-01 |
| COVID-19 Vaccination in Rheumatic Disease Patients (NCT04839315) | Mayo Clinic | 2021-02-15 |
| Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc (NCT05292456) | Hacettepe University | 2021-02-01 |
| Objective Measurement With TCM Pattern for AIDDES (NCT04747288) | Taipei Veterans General Hospital, Taiwan | 2021-02-01 |
| Belimumab in Patients With Systemic Lupus Erythematosus (NCT04671706) | Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas (GEAS) de la Fundación Española de Medicina | 2021-01-01 |
| Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage (NCT04558814) | Assiut University | 2021-01-01 |
| A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus (NCT04700267) | Lakefront Biotherapeutics NV | 2020-12-28 |
| Transcriptional and Immune Parameters of Response to Belimumab (NCT04570306) | Biomedical Research Foundation, Academy of Athens | 2020-12-16 |
| Study of M5049 in CLE and SLE Participants (NCT04647708) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2020-12-16 |
| Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study (NCT04431167) | University of Sao Paulo | 2020-12-01 |
| Epigenetics in Lupus Nephritis (NCT04648059) | University of Göttingen | 2020-12-01 |
| Monogenic Lupus in Childhood Onset Systemic Lupus Erythematosus (NCT04532541) | Children's Hospital of Fudan University | 2020-11-25 |
| The Effectiveness of Walking in Patients With Systemic Lupus Erythematosus (NCT04983784) | Dalin Tzu Chi General Hospital | 2020-11-01 |
| Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation (NCT04320680) | University Hospital, Brest | 2020-10-13 |
| Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU (NCT06551389) | University Hospital, Brest | 2020-10-13 |
| The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata (NCT04239521) | Momentum Data | 2020-10-01 |
| Individual Patient Exposure and Response in Pediatric Lupus (NCT04358302) | Duke University | 2020-09-28 |
| Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases (NCT06029335) | University of Pecs | 2020-09-01 |
| The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases (NCT04397107) | The First Hospital of Jilin University | 2020-08-15 |
| Rheumatology Patient Registry and Biorepository (NCT04402086) | Yale University | 2020-08-04 |
| Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus (NCT04335643) | Michigan State University | 2020-08-04 |
| BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis (NCT05659407) | University of Cagliari | 2020-07-24 |
| PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE (NCT04411407) | Salome Kristensen | 2020-07-15 |
| Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus Erythematosus (NCT04293510) | Assiut University | 2020-07-15 |
| A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE) (NCT04305197) | Beijing InnoCare Pharma Tech Co., Ltd. | 2020-07-09 |
| AS-OCT Study of Cornea and Tear Film Parameters in SLE Patients (NCT04873739) | Minia University | 2020-07-01 |
| Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe (NCT04397237) | Pitié-Salpêtrière Hospital | 2020-06-10 |
| Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases (NCT04530461) | faida agili | 2020-06-01 |
| Long-Term Outcomes in SLE at Peking University People's Hospital (NCT07005479) | Peking University People's Hospital | 2020-05-21 |
| COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases (NCT04335747) | Salome Kristensen | 2020-04-23 |
| Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease (NCT04345159) | Fondation Ophtalmologique Adolphe de Rothschild | 2020-04-17 |
| Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus (NCT04356014) | University Hospital, Montpellier | 2020-04-01 |
| Covid-19 in Lupus Patients (NCT04355702) | University Hospital, Montpellier | 2020-03-01 |
| Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients (NCT05430087) | Saiful Anwar Hospital | 2020-03-01 |
| Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases. (NCT04180228) | Hospices Civils de Lyon | 2020-01-23 |
| Haematological Indices in Systemic Lupus Erythematosus (NCT04110184) | Assiut University | 2019-12-01 |
| Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) (NCT04179032) | GlaxoSmithKline | 2019-11-28 |
| Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions (NCT03938324) | Duke University | 2019-10-29 |
| Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects (NCT04136145) | GlaxoSmithKline | 2019-10-28 |
| The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus (NCT04275193) | Shanghai University of Traditional Chinese Medicine | 2019-10-22 |
| Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) (NCT04082416) | RemeGen Co., Ltd. | 2019-10-16 |
| Reducing Disparities in Medication Adherence in SLE (NCT03738826) | Duke University | 2019-10-02 |